Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rémy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital
-
MINING LEASE APPLICATION SUBMITTED FOR NORRA KÄRR
-
ALSTOM SA: Alstom to supply 35 additional RER NG trains for the RER E line on the Île-de-France Mobilités network
-
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver
-
HAFNIA LIMITED: Transactions made under share buyback program
-
Global Times: China enhances village inspection to crack down on corruption at grassroot level as anti-graft campaign enters uncharted water
-
Zadarma, a Telecom Holding, Acquires US VoIP Provider VoIPVoIP
-
Researchers Highlight Urgent Need for Land Restoration and Food System Reforms to Protect Climate and Biodiversity
-
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
-
Pantheon Resources PLC Announces Final Results for the Year Ended 30 June 2024
-
Orosur Mining Inc Announces Colombia update
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 09
-
Touchstone Exploration Announces Preliminary 2025 Guidance
-
Gentari to supply large-scale, carbon-free energy to AMG Ammonia
-
Northern Data Group presents AI-enabled film "The Glass Hermit" by Oscar-winner Shona Heath
-
TrinaTracker unlocks its SuperTrack potential, with annual power generation increased 2% to 4%
-
Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
-
Clariane: Renewal of the Revolving Credit Facility for a Six-Month Period
-
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
-
Ferguson Files Form 8-K
-
AAVantgarde presents safety data of the first two subjects dosed in the LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B at FLORetina 2024
-
Caledonia Mining Corporation Plc: Purchase of Securities by Director
-
Pulsar Helium Commences Field Activities for Deepening the Jetstream #1 Appraisal Well at the Topaz Project in Minnesota, USA
-
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance
-
Shell plc Third Quarter 2024 Euro and GBP Equivalent Dividend Payments
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 5)
-
INVL Partner Global Real Estate Fund I raises additional USD 1.19 million
-
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
-
Kester Capital backs experienced management team in acquiring EMAS Pharma
-
Moma update
-
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
-
Vow ASA: Last day of the subscription period in the rights issue
-
Transaction in Own Shares
-
Subsea7 share repurchases
-
KFSHRC Leads Innovation in Cancer Radiopharmaceuticals
-
New Final Bond Terms for Nykredit Realkredit A/S's Base Prospectus dated 8 May 2024 - Nykredit Realkredit A/S
-
Skanska signs contract for the next part of NKT's cable factory in Karlskrona, Sweden, worth about SEK 1.2 billion
-
Kima Chemical Announces Annual Production Capacity of 20,000 Tons of Cellulose Ether
-
Lleida.net's monthly turnover customers over 5,000 euros per month increase 38.6% in the period from November 2023 to November 2024
-
Poxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook
-
Havila Shipping ASA: Financing update and invitation to fixed income investor meetings
-
Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement
-
Boliden to acquire the Neves-Corvo and Zinkgruvan mines
-
$300 Billion in Estimated Annual Consumer Harm Linked to Fake Reviews, Transparency Company Research Report Reveals
-
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
-
Leukogene Therapeutics Welcomes Industry Veteran and Leader Dr. Sandeep Gupta as Its Chief Executive Officer
-
-
Nearshoring Trend Continues as CTP Signs 19,000 sqm Deal With Chinese Manufacturer in Serbia
-
HIVE Digital Technologies Announces November 2024 Production Results and Strategic Milestones
-
Bayport Management Ltd updates the prospective record date and exchange date for the exchange of its outstanding senior and subordinated social bonds.
